These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11558710)

  • 1. Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS.
    Lichtenberg FR
    Health Aff (Millwood); 2001; 20(5):241-51. PubMed ID: 11558710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of newer drugs on health spending: do they really increase the costs?
    Civan A; Köksal B
    Health Econ; 2010 May; 19(5):581-95. PubMed ID: 19404925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do higher drug costs lead to better health?
    Mintzes B; Lexchin J
    Can J Clin Pharmacol; 2005; 12(1):e22-7. PubMed ID: 16055941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-offsets of prescription drug expenditures: data analysis via a copula-based bivariate dynamic hurdle model.
    Deb P; Trivedi PK; Zimmer DM
    Health Econ; 2014 Oct; 23(10):1242-59. PubMed ID: 23956147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-related morbidity and mortality: an economic and clinical perspective.
    Bootman JL
    Manag Care; 2002 Feb; 11(2 Suppl):12-5. PubMed ID: 11907995
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of new drugs on overall health spending: Frank Lichtenberg responds.
    Lichtenberg FR
    Health Aff (Millwood); 2007; 26(3):887-90. PubMed ID: 17485771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Prescription Drug Spending Leading Up to Health Reform.
    Blavin F; Waidmann T; Blumberg LJ; Roth J
    Med Care Res Rev; 2014 Aug; 71(4):416-32. PubMed ID: 24830379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drugs and the changing concentration of health care expenditures.
    Zuvekas SH; Cohen JW
    Health Aff (Millwood); 2007; 26(1):249-57. PubMed ID: 17211035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.
    Cawley J; Meyerhoefer C; Biener A; Hammer M; Wintfeld N
    Pharmacoeconomics; 2015 Jul; 33(7):707-22. PubMed ID: 25381647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey.
    Valero-Elizondo J; Salami JA; Ogunmoroti O; Osondu CU; Aneni EC; Malik R; Spatz ES; Rana JS; Virani SS; Blankstein R; Blaha MJ; Veledar E; Nasir K
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):143-53. PubMed ID: 26941417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care for children and youth in the United States: annual report on patterns of coverage, utilization, quality, and expenditures by income.
    Simpson L; Owens PL; Zodet MW; Chevarley FM; Dougherty D; Elixhauser A; McCormick MC
    Ambul Pediatr; 2005; 5(1):6-44. PubMed ID: 15656707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Needs of cost-effectivity analysis for the optimization and rationalization of expense in new drugs].
    Soto Alvarez J
    Med Clin (Barc); 2008 Apr; 130(14):559. PubMed ID: 18457627
    [No Abstract]   [Full Text] [Related]  

  • 14. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in mental health insurance benefits and out-of-pocket spending.
    McKusick DR; Mark TL; King EC; Coffey RM; Genuardi J
    J Ment Health Policy Econ; 2002 Jun; 5(2):71-8. PubMed ID: 12529560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression-based sampling for persons with high health expenditures: evaluating accuracy and yield with the 1997 MEPS.
    Moeller JF; Cohen SB; Mathiowetz NA; Wun LM
    Med Care; 2003 Jul; 41(7 Suppl):III44-III52. PubMed ID: 12865726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of extended longitudinal profiles in predicting future health care expenditures.
    Cohen SB; Ezzati-Rice T; Yu W
    Med Care; 2006 May; 44(5 Suppl):I45-53. PubMed ID: 16625064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out-of-Pocket Spending for Ambulatory Physical Therapy Services From 2008 to 2012: National Panel Survey.
    Chevan J; Riddle DL; Reed SD
    Phys Ther; 2015 Dec; 95(12):1680-91. PubMed ID: 26112257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on drugs.
    Vail S
    Can Nurse; 1996 Jan; 92(1):60, 59. PubMed ID: 8920559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of Medicare expenditures in the medical expenditure panel survey.
    Zuvekas SH; Olin GL
    Inquiry; 2009; 46(1):92-108. PubMed ID: 19489486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.